News & Events zu Guardant Health Inc (GH)GHGuardant Health Inc

Guardant Health's Shield Blood Test to be Covered by Carelon Healthcare Services from November 15

Guardant Health announced its Shield blood test for colorectal cancer screening will be covered in Carelon Healthcare Services clinical guidelines effective November 15. Carelon Healthcare Services is one of the largest specialty benefits managers in the country and subsidiary of one of the largest health insurance companies in the U.S spanning more than 14 states. Shield is a blood test for CRC screening detection as the first FDA-approved blood test for primary colorectal cancer screening in average-risk adults age 45 and older. The updated policy coverage from Carelon offers those above the age of 45 and at average risk of colorectal cancer access to the latest innovation in colorectal cancer screening, amid rising CRC rates for adults under 651 and mortality for younger adults as the leading cause of cancer death for those under 50.

Guardant Health to Appeal Delaware Court Judgment

Guardant Health announced it will appeal the final judgment from the U.S. District Court for the District of Delaware related to intellectual property claims brought against Guardant by TwinStrand Biosciences, Inc. and University of Washington, with execution of the final judgment and collection of potential royalties stayed pending appeal. "We strongly disagree with this decision and will promptly be appealing for its overturn," said John Saia, Guardant Health Chief Legal Officer. "We have full faith in the strengths and merits of Guardant's intellectual property and R&D and are confident we will ultimately prevail on appeal."

Amazon Earnings Beat Expectations, Stock Rises Nearly 10%

Semiconductors, Equipment, Memory, and Hardware stocks rallied hard on Thursday, with investors inclined to bottom-fish in the AI capex buildout theme which has dogged market sentiment for over a month.  Names like Sandisk, Micron, Lam Research, and Western Digitalwere up double-digits on the session, also boosting many Industrials involved in the AI ecosystem, while the "made-obsolete-by AI" spaces of the market - Software, Travel Services, Insurance, and Enterprise IT - lagged.  Other counter-cyclicalsectors which had helped to keep the market from falling off a cliff for weeks - namely Healthcare and Staples - also saw significant outflows.  While all major indices were sharply higher however, skeptical voices question the sustainability of the rebound.  The lack of "market breadth" is one of the biggest concerns and with merit - despite the sharp bounce today, less than 200 names in the S&P 500 were higher on the session.In the opening hours of the evening session, Nasdaq 100 is holding up Thursday's bullishness with a 0.6% rise, while S&P 500 futures are up a more modest 0.2%.  Afterhours, the spotlight fell on results from Amazon.comand Apple.  Amazon ended the afterhours session up nearly 10% as earnings blew away consensus thanks to 37% growth in its Amazon Web Services cloud unit.  Apple, however, was down 6%, spoiling CEO Tim Cook's final earnings call, as the company's softer than expected revenue outlook for September quarter overshadowed its strong performance in Q3.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -Cohuup 16.1%Ryan Specialty Holdingsup 13.4%Monolithic Power Systemsup 9.6%Amazon.comup 9.0%DexComup 7.3%Guardant Healthup 6.5%SPX Technologiesup 6.4%Merit Medical Systemsup 4.7%DOWN AFTER EARNINGS -MasTecdown 15.2%Robloxdown 13.8%Redditdown 10.3%Veracytedown 9.7%GoDaddydown 8.2%Strykerdown 7.5%Appledown 5.9%Coinbase Globaldown 5.2%Cortevadown 1.6%